GBA Presents: THE GREEN MARKET
- Thread starter stonedinvestor
- Start date
Stoney!
School is in session.
Professor VZ will now cover Savanting 101....
Where are the Q's this morning?
369!!!?
How's he do it?!
Stick with me Stoney, I've got your back.
School is in session.
Professor VZ will now cover Savanting 101....
Where are the Q's this morning?
369!!!?
How's he do it?!
Stick with me Stoney, I've got your back.
Stoney!
CNBC is being awful calm.
Don't be fooled!
They don't want to incite a panic.
A good day to break out granny's shopping list.
Tomorrow might be even better though.
Watch those falling chainsaws.
This is coming from the guy that bought BSC @ $34.
(That would be Bear Sterns for any Robin-hoodies here. Before your day.)
CNBC is being awful calm.
Don't be fooled!
They don't want to incite a panic.
A good day to break out granny's shopping list.
Tomorrow might be even better though.
Watch those falling chainsaws.
This is coming from the guy that bought BSC @ $34.
(That would be Bear Sterns for any Robin-hoodies here. Before your day.)
The hits keep coming....
VMC to Granny's shorts Stoney?
$170
++++++++++++++++++++++++++++++
Manchin suggests pausing talks on $3.5 trillion package until 2022
Sen. Joe Manchin (D-W.Va.) has suggested pausing discussions on a $3.5 trillion spending package until 2022 as the House gets ready to vote on a bipartisan deal next week, Axios reported, citing people familiar with the matter.
Manchin has publicly suggested a "strategic pause" in talks over the legislation, but hadn't suggested a specific timeline.
Manchin suggested pausing until next year while talking with workers in Martinsburg, West Virginia last week, and has made similar comments in private, Axios reported.
VMC to Granny's shorts Stoney?
$170
++++++++++++++++++++++++++++++
Manchin suggests pausing talks on $3.5 trillion package until 2022
Sen. Joe Manchin (D-W.Va.) has suggested pausing discussions on a $3.5 trillion spending package until 2022 as the House gets ready to vote on a bipartisan deal next week, Axios reported, citing people familiar with the matter.
Manchin has publicly suggested a "strategic pause" in talks over the legislation, but hadn't suggested a specific timeline.
Manchin suggested pausing until next year while talking with workers in Martinsburg, West Virginia last week, and has made similar comments in private, Axios reported.
not to worry, the FED will come in Wednesday with the obligatory handjob and some relief will "temporarily" be felt.
GOOD MORNING! LETS GO SHOPPING!!!! 
Ginkgo Bioworks initiated with a Buy at HSBC 05:39 DNA HSBC analyst Sriharsha
-- 1st analyst action.
--OraSure receives $205M procurement contract for InteliSwab 06:07 OSUR OraSure Technologies announced that the Defense Logistics Agency has awarded the Company a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use, which the Defense Logistics Agency estimated to have a value of $205M. Under the terms of the contract, OraSure will provide its InteliSwab COVID-19 Rapid Test to up to 25,000 sites throughout the United States and the tests will be funded by the U.S. federal government. The contract will run from October 2021 through September 2022. InteliSwab is a simple "swab, swirl, see" test that uses an integrated swab to self-collect a sample from the lower nostrils. The result appears right on the test stick within 30 minutes, with no instruments, batteries, smartphone or laboratory analysis needed. It has three Emergency Use Authorizations from the Food and Drug Administration for professional point-of-care use, prescription home use, and over-the-counter use. As the Company ramps to meet the requirements in this contract, it anticipates having significant incremental manufacturing and operating expenses in the second half of fiscal year 2021. Additionally, given the volume ramp implied in the contract, the Company expects the preponderance of revenue associated with the contract to come in calendar year 2022.
--PAE initiated with a Buy at BofA 06:03 PAE BofA initiated coverage of PAE with a Buy rating and $8 price target.
--Vision Marine Technologies to showcase E-Motion electric outboard motor 07:38 VMAR
--Ayr Wellness opens new dispensary in West Pensacola 07:36 AYRWF Ayr Wellness announced the opening of Liberty Health Sciences West Pensacola, the Company's 41st operating dispensary in Florida. The West Pensacola dispensary is located at 2146 W. 9 Mile Rd, Pensacola, Florida. The 1,330 sq. ft. retail store expands the Company's presence in the important Pensacola market, the westernmost city in the Florida Panhandle and one of the largest metropolitan areas in the Gulf Coast region with a population of over 500,000.
--Sprout Social price target raised to $153 from $112 at KeyBanc » 07:35 SPT, CXM
--Thermo Fisher price target raised to $700 from $600 at JPMorgan 07:32 TMO
--PyroGenesis joins two FTSE Russell Indexes 06:58 PYR PyroGenesis Canada is pleased to announced that it has been added to the FTSE Global Total Cap Index and FTSE Global Micro Cap Index, following the semi-annual reconstitution, which takes effect at the start of trading today, September 20, 2021.
--Sale of Voyager more likely than out-licensing, says Benchmark 06:45 VYGR
--Li-Cycle initiated with an Outperform at Wedbush 06:39 LICY Wedbush analyst Daniel Ives initiated coverage of Li-Cycle with an Outperform rating and $14 price target. Li-Cycle is in the lithium-ion battery resource recovery sector serving as the largest North American company within its space, Ives tells investors in a research note. The analyst says the company is a pure-play lithium-ion recycler as it breaks down battery waste to extract the precious materials lithium, nickel, and cobalt to cycle them back out into the supply chain. He believes Li-Cycle has "primed itself to continue its dominance across the battery recycling sector."
2nd House to pick up coverage!
-Adagio Therapeutics expands patient population in EVADE Phase 2/3 trial 06:36 ADGI
--Verastem jumps 27% to $3.50 per share after data on VS-6766 in ovarian cancer 06:16 VSTM
Sprout Social price target raised to $150 from $110 at BTIG 06:11 SPT BTIG analyst Matt VanVliet raised the firm's price target on Sprout Social to $150 from $110 and keeps a Buy rating on the shares ahead of its inaugural investor day on September 22nd. The analyst believes that the company is "just starting to scratch the surface", and he expects to get more detail from the management on how it plans to capture the "large and growing" market opportunity for broader social media management adoption.
Ginkgo Bioworks initiated with a Buy at HSBC 05:39 DNA HSBC analyst Sriharsha
-- 1st analyst action.
--OraSure receives $205M procurement contract for InteliSwab 06:07 OSUR OraSure Technologies announced that the Defense Logistics Agency has awarded the Company a procurement contract for its InteliSwab COVID-19 Rapid Test for over-the-counter use, which the Defense Logistics Agency estimated to have a value of $205M. Under the terms of the contract, OraSure will provide its InteliSwab COVID-19 Rapid Test to up to 25,000 sites throughout the United States and the tests will be funded by the U.S. federal government. The contract will run from October 2021 through September 2022. InteliSwab is a simple "swab, swirl, see" test that uses an integrated swab to self-collect a sample from the lower nostrils. The result appears right on the test stick within 30 minutes, with no instruments, batteries, smartphone or laboratory analysis needed. It has three Emergency Use Authorizations from the Food and Drug Administration for professional point-of-care use, prescription home use, and over-the-counter use. As the Company ramps to meet the requirements in this contract, it anticipates having significant incremental manufacturing and operating expenses in the second half of fiscal year 2021. Additionally, given the volume ramp implied in the contract, the Company expects the preponderance of revenue associated with the contract to come in calendar year 2022.
--PAE initiated with a Buy at BofA 06:03 PAE BofA initiated coverage of PAE with a Buy rating and $8 price target.
--Vision Marine Technologies to showcase E-Motion electric outboard motor 07:38 VMAR
--Ayr Wellness opens new dispensary in West Pensacola 07:36 AYRWF Ayr Wellness announced the opening of Liberty Health Sciences West Pensacola, the Company's 41st operating dispensary in Florida. The West Pensacola dispensary is located at 2146 W. 9 Mile Rd, Pensacola, Florida. The 1,330 sq. ft. retail store expands the Company's presence in the important Pensacola market, the westernmost city in the Florida Panhandle and one of the largest metropolitan areas in the Gulf Coast region with a population of over 500,000.
--Sprout Social price target raised to $153 from $112 at KeyBanc » 07:35 SPT, CXM
--Thermo Fisher price target raised to $700 from $600 at JPMorgan 07:32 TMO
--PyroGenesis joins two FTSE Russell Indexes 06:58 PYR PyroGenesis Canada is pleased to announced that it has been added to the FTSE Global Total Cap Index and FTSE Global Micro Cap Index, following the semi-annual reconstitution, which takes effect at the start of trading today, September 20, 2021.
--Sale of Voyager more likely than out-licensing, says Benchmark 06:45 VYGR
--Li-Cycle initiated with an Outperform at Wedbush 06:39 LICY Wedbush analyst Daniel Ives initiated coverage of Li-Cycle with an Outperform rating and $14 price target. Li-Cycle is in the lithium-ion battery resource recovery sector serving as the largest North American company within its space, Ives tells investors in a research note. The analyst says the company is a pure-play lithium-ion recycler as it breaks down battery waste to extract the precious materials lithium, nickel, and cobalt to cycle them back out into the supply chain. He believes Li-Cycle has "primed itself to continue its dominance across the battery recycling sector."
2nd House to pick up coverage!
-Adagio Therapeutics expands patient population in EVADE Phase 2/3 trial 06:36 ADGI
--Verastem jumps 27% to $3.50 per share after data on VS-6766 in ovarian cancer 06:16 VSTM
Sprout Social price target raised to $150 from $110 at BTIG 06:11 SPT BTIG analyst Matt VanVliet raised the firm's price target on Sprout Social to $150 from $110 and keeps a Buy rating on the shares ahead of its inaugural investor day on September 22nd. The analyst believes that the company is "just starting to scratch the surface", and he expects to get more detail from the management on how it plans to capture the "large and growing" market opportunity for broader social media management adoption.